CORNELIA M WEYAND, M.D.
Osteopathic Medicine at Pasteur Dr, Palo Alto, CA

License number
California C54171
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 723-6961
(650) 498-7103

Professional information

Cornelia M Weyand Photo 1

Dr. Cornelia M Weyand, Atlanta GA - MD (Doctor of Medicine)

Specialties:
Rheumatology
Address:
Emory Clinic Endocrinology/Rheu
1365 Clifton Rd NE, Atlanta 30322
(404) 778-5728 (Phone)
300 Pasteur Dr, Stanford 94305
(650) 723-6961 (Phone)
Conditions:
Arthritis, Classic Polyarteritis Nodosa, Cryoglobulinemia, Fibromyalgia, Giant Cell Arteritis, Gout, Osteoarthritis, Systemic Vasculitis, Takayasu's Arteritis, Vasculitis, Wegener's Granulomatosis
Languages:
English
Hospitals:
Emory Clinic Endocrinology/Rheu
1365 Clifton Rd NE, Atlanta 30322
300 Pasteur Dr, Stanford 94305
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
Education:
Medical School
Rheinisch-Westfalische Technical College / Medical Faculty


Cornelia Maritta Weyand Photo 2

Cornelia Maritta Weyand, Atlanta GA

Specialties:
Allergy & Immunology, Internal Medicine, Rheumatology, Immunopathology
Work:
The Emory Clin
1365 Clifton Rd Ne, Atlanta, GA 30322 Immunology & Rheumatology
300 Pasteur Dr, Stanford, CA 94305 Grady Memorial Hospital
80 Jesse Hill Jr Dr SE, Atlanta, GA 30303 Stanford University
269 Campus Dr, Stanford, CA 94305
Education:
Rheinisch-Westfalische Technische Hochschule Aachen (1980)


Cornelia Weyand Photo 3

Methods To Enhance T-Cell Mediated Immune Response

US Patent:
2011028, Nov 17, 2011
Filed:
Apr 8, 2011
Appl. No.:
13/082790
Inventors:
Jorg J. Goronzy - Palo Alto CA, US
Cornelia Weyand - Palo Alto CA, US
Guangjin Li - Mountain View CA, US
Mingcan Yu - Palo Alto CA, US
Assignee:
The U.S. Government represented by the Department of Veterans Affairs - Washington DC
The Board of Trustees of the Leland Stanford Junior University - Palo Atlo CA
International Classification:
A61K 31/7105, A61P 37/04
US Classification:
514 44 A
Abstract:
The present invention provides methods for restoring or enhancing T cell mediated immune response in individuals of middle and advanced age.


Cornelia Weyand Photo 4

Immune System Function In Conditions Characterized By Elevated Double Strand Breaks

US Patent:
2012003, Feb 16, 2012
Filed:
Aug 8, 2011
Appl. No.:
13/205001
Inventors:
Cornelia M. Weyand - Stanford CA, US
Jörg J. Goronzy - Palo Alto CA, US
Lan Shao - Stanford CA, US
International Classification:
A61K 39/395, A61K 31/7088, A61K 31/7105, A61P 19/02, C12Q 1/02, A61K 31/711, A61P 37/02, C12N 5/078, A61K 38/00
US Classification:
4241301, 435375, 514 44 R, 514 44 A, 514 166, 514 189, 435 29
Abstract:
Methods and compositions for improving immune system function are provided. These methods find particular use in improving immune system function in individuals with a condition in which naïve lymphocytes comprise elevated amounts of DNA double strand breaks (DSB), for example, individuals with Rheumatoid Arthritis, individuals that have received a bone marrow transplant, or elderly individuals, e.g. individuals that are 50 or more years old. Also provided are methods and compositions for screening for novel compounds that will improve immune system function in such individuals.


Cornelia Weyand Photo 5

Biomarkers For The Diagnosis Of Autoimmune Disease

US Patent:
2012006, Mar 15, 2012
Filed:
Sep 13, 2011
Appl. No.:
13/231282
Inventors:
Jörg J. Goronzy - Palo Alto CA, US
Cornelia M. Weyand - Stanford CA, US
International Classification:
A61K 38/02, A61P 19/02, G01N 21/76, C40B 30/00, C12Q 1/48, G01N 33/573
US Classification:
514 166, 435 15, 435 724, 506 7
Abstract:
Compositions and methods are provided for diagnosis and treatment of rheumatoid arthritis. Defects in T cell receptor signaling lower the activation threshold of RA T cells, thus predisposing for a failure in maintenance of immune tolerance. Overexpression of B-Raf and/or K-Ras in CD4 T cells lowers the threshold to respond to TCR triggering in the absence of costimulation and increases responses to citrullinated peptides and other autoantigens.